4 news items
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
BAX
RAPT
RENB
21 May 24
the latest list of major oversold players in this sector, having an RSI near or below 30.
Treace Medical
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
SAGE
25 Apr 24
Payor coverage now in place for a majority of commercially covered lives for ZURZUVAE in the treatment of women with postpartum depression (PPD
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
SAGE
17 Apr 24
treatment-emergent adverse events (TEAEs). The vast majority of TEAES were mild to moderate in severity.
“We are disappointed
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson's Disease
SAGE
17 Apr 24
. A total of 48 participants experienced treatment emergent adverse events (TEAEs). The vast majority of TEAES were mild to moderate in severity
- Prev
- 1
- Next